Susan M Blaney Selected Research

Imatinib Mesylate (Gleevec)

3/2011	Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.
1/2009	Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
2/2008	A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
4/2007	Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
11/2004	Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.
4/2004	Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan M Blaney Research Topics

Disease

101	Neoplasms (Cancer) 01/2021 - 02/2003
23	Brain Neoplasms (Brain Tumor) 01/2020 - 08/2004
19	Glioma (Gliomas) 01/2020 - 04/2004
19	Leukemia 01/2019 - 11/2004
17	Neutropenia 01/2020 - 11/2006
13	Thrombocytopenia (Thrombopenia) 04/2015 - 12/2004
11	Medulloblastoma 09/2013 - 12/2005
10	Fatigue 01/2020 - 07/2004
9	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 11/2006
8	Neuroblastoma 01/2021 - 11/2006
8	Central Nervous System Neoplasms 01/2020 - 03/2007
8	Vomiting 02/2018 - 11/2004
8	Nausea 05/2015 - 08/2004
7	Diarrhea 11/2012 - 11/2004
6	Exanthema (Rash) 01/2020 - 06/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 05/2007
5	Ependymoma 01/2021 - 06/2010
5	Osteosarcoma (Osteogenic Sarcoma) 01/2016 - 11/2006
5	Rhabdomyosarcoma 09/2015 - 03/2008
5	Anemia 05/2015 - 08/2011
5	Sarcoma (Soft Tissue Sarcoma) 03/2015 - 11/2006
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2020 - 05/2013
4	Hypertension (High Blood Pressure) 01/2020 - 11/2012
4	Meningitis 04/2013 - 01/2003
4	Anorexia 03/2013 - 07/2004
4	Hypokalemia 08/2011 - 04/2009
4	Headache (Headaches) 04/2009 - 01/2005
3	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2020
3	Disease Progression 01/2021 - 09/2005
3	Hemorrhage 01/2020 - 04/2007
3	Mucositis 01/2017 - 11/2012
3	Lymphopenia (Lymphocytopenia) 05/2015 - 08/2011
3	Leukopenia 05/2015 - 07/2004
3	Hypocalcemia 08/2011 - 02/2003
3	Abdominal Pain (Pain, Abdominal) 04/2010 - 01/2008
3	Primitive Neuroectodermal Tumors (PNET) 11/2006 - 12/2005
2	Hypersensitivity (Allergy) 01/2018 - 03/2009
2	Lymphoma (Lymphomas) 01/2018 - 01/2008
2	Wilms Tumor (Wilm's Tumor) 09/2015 - 01/2010
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2014 - 01/2006
2	Plexiform Neurofibroma 09/2014 - 01/2006
2	Infections 09/2013 - 06/2008
2	Proteinuria 08/2013 - 08/2006
2	Arachnoiditis 04/2013 - 03/2006
2	Hypophosphatemia 02/2013 - 08/2011

Drug/Important Bio-Agent (IBA)

10	Biological ProductsIBA 01/2016 - 08/2006
9	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 11/2007
8	Alanine Transaminase (SGPT)IBA 02/2018 - 11/2006
6	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 04/2004
5	CrizotinibIBA 01/2021 - 05/2013
5	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 12/2005
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 04/2007
5	Pharmaceutical PreparationsIBA 09/2013 - 07/2005
5	ErbB Receptors (EGF Receptor)IBA 09/2013 - 09/2005
5	Topotecan (Hycamtin)FDA LinkGeneric 04/2013 - 01/2003
5	Irinotecan (Camptosar)FDA LinkGeneric 04/2010 - 02/2003
4	dipinacoline glutamateIBA 01/2022 - 02/2018
4	Vorinostat FDA Link 01/2022 - 08/2010
4	veliparibIBA 01/2020 - 08/2009
4	Alkaline PhosphataseIBA 01/2017 - 08/2011
4	Tyrosine Kinase InhibitorsIBA 01/2016 - 04/2004
4	CreatinineIBA 10/2015 - 08/2006
4	cixutumumabIBA 04/2015 - 01/2012
4	EnzymesIBA 05/2013 - 07/2004
4	Bortezomib (Velcade)FDA Link 03/2013 - 12/2004
4	Transaminases (Aminotransferases)IBA 08/2011 - 11/2004
3	Histone Deacetylase InhibitorsIBA 01/2022 - 08/2006
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 02/2010
3	Sunitinib (Sutent)FDA Link 01/2016 - 08/2011
3	Biomarkers (Surrogate Marker)IBA 03/2015 - 09/2007
3	Histone Deacetylases (Histone Deacetylase)IBA 09/2013 - 08/2006
3	Amylases FDA Link 08/2013 - 03/2008
3	Lipase (Acid Lipase)FDA Link 08/2013 - 03/2008
3	Pemetrexed (MTA)FDA Link 02/2013 - 03/2007
3	mafosfamideIBA 09/2012 - 01/2005
3	tipifarnib (R115777)IBA 02/2011 - 01/2006
3	Gefitinib (Iressa)FDA Link 12/2010 - 09/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010 - 07/2006
3	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2008 - 01/2006
3	Proteasome InhibitorsIBA 03/2007 - 12/2004
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 05/2013
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2008
2	MLN 8237IBA 01/2019 - 11/2012
2	Capecitabine (Xeloda)FDA Link 02/2018 - 06/2013
2	TabletsIBA 02/2018 - 06/2013
2	Asparaginase (Elspar)FDA Link 01/2018 - 07/2006
2	Gemcitabine FDA Link 01/2018 - 07/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016 - 02/2008
2	Sorafenib (BAY 43-9006)FDA Link 09/2015 - 11/2012
2	temsirolimus FDA Link 04/2015 - 03/2015
2	ElectrolytesIBA 03/2015 - 01/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2014 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 09/2013 - 12/2010
2	Lapatinib (GW572016)FDA Link 09/2013 - 09/2010

Therapy/Procedure

25	Therapeutics 01/2022 - 12/2004
9	Drug Therapy (Chemotherapy) 12/2020 - 01/2005
8	Radiotherapy 01/2022 - 04/2006
4	Intravenous Infusions 02/2013 - 11/2006
3	Lasers (Laser) 08/2012 - 01/2008
2	Intravenous Injections 09/2013 - 01/2011